Allergan Plc Quick Ratio (AGN) starting from the first quarter 2020 to first quarter 2019, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Allergan plc  (NYSE: AGN)

Allergan Plc's Quick Ratio

AGN's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


Regardless of the sequential decrease in Current Liabilities, during the first quarter 2020, Quick Ratio deteriorated to 0.35 below Allergan Plc's average Quick Ratio.

Within Major Pharmaceutical Preparations industry 439 other companies have achieved higher Quick Ratio than Allergan Plc in first quarter 2020. While Quick Ratio total ranking in the first quarter 2020 has deteriorated compared to the prior quarter from 2624 to 3123.

Explain Quick Ratio?
How much Cash & cash equivalents AGN´s has?
What are AGN´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

AGN Quick Ratio (Mar 31 2020)
Q1		 (Dec 31 2019)
Q4		 (Sep 30 2019)
Q3		 (Jun 30 2019)
Q2		 (Mar 31 2019)
Q1
Y / Y Current Liabilities Change -16.01 % 94.4 % -51.95 % -61.77 % 52.14 %
Y / Y Cash & cash equivalent Change 46.79 % 210.12 % 276.55 % 16.36 % -12.23 %
Quick Ratio MRQ 0.35 0.53 0.47 0.24 0.2
AGN's Total Ranking # 3123 # 2624 # 1154 # 2683 # 3744
Seq. Current Liabilities Change -33.24 % 15.53 % 16.08 % -6.18 % 54.52 %
Seq. Cash & cash equivalent Change -55.73 % 29.83 % 130.83 % 10.65 % -6.48 %



Quick Ratio first quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 440
Healthcare Sector # 795
Overall Market # 3123


Quick Ratio Statistics
High Average Low
3.19 1.6 0.06
IV. Quarter  




Financial Statements
Allergan Plc's Current Liabilities $ 7,433 Millions Visit AGN's Balance sheet
Allergan Plc's Cash & cash equivalent $ 2,618 Millions Visit AGN's Balance sheet
Source of AGN's Sales Visit AGN's Sales by Geography


Cumulative Allergan Plc's Quick Ratio

AGN's Quick Ratio for the trailling 12 Months

AGN Quick Ratio

 (Mar 31 2020)
12 Months		 (Dec 31 2019)
12 Months		 (Sep 30 2019)
12 Months		 (Jun 30 2019)
12 Months		 (Mar 31 2019)
12 Months
Y / Y Current Liabilities TTM Growth -35.22 % -28.87 % -43.41 % -6.64 % 71.11 %
Y / Y Cash & cash equivalent TTM Growth 128.32 % 107.84 % -10.25 % -55.99 % -66.6 %
Quick Ratio TTM 0.41 0.38 0.31 0.16 0.12
Total Ranking TTM # 5005 # 5024 # 1294 # 2541 # 2302
Seq. Current Liabilities TTM Growth -3.74 % 16.63 % -24.27 % -23.81 % 5.69 %
Seq. Cash & cash equivalent TTM Growth 5.87 % 39.21 % 48.67 % 4.21 % -3.63 %

Quick ratio ranking by company, industry and sector >> Back to AGN Financial Strength Comparisons >> Go to Compare AGN Quick Ratio to its Competitors

On the trailing twelve months basis AGN Cash & cash equivalent soared by 46.79 % in Q1 2020 year on year, while Current Liabilities plummeted to $7,433 millions, this led to increase in in Allergan Plc's Quick Ratio to 0.41, Quick Ratio remained below AGN average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Major Pharmaceutical Preparations industry 501 other companies have achieved higher Quick Ratio than Allergan Plc. While Quick Ratio overall ranking has improved so far to 5005, from total ranking during the twelve months ending fourth quarter 2019 at 5024.

Explain Quick Ratio?
How much Cash & cash equivalents AGN´s has?
What are AGN´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Major Pharmaceutical Preparations Industry # 502
Healthcare Sector # 972
Within the Market # 5005


trailing twelve months Quick Ratio Statistics
High Average Low
2.85 1.59 0.17
IV. Quarter   (Jun 30 2016)




Companies with similar Quick Ratio in the quarter ending Mar 31 2020, within Major Pharmaceutical Preparations Industry Quick RatioMar 31 2020 MRQ Cash & cash equivalentMar 31 2020 MRQ Current Liabilities
Neptune Wellness Solutions Inc   0.96 $ 12.698  Millions$ 13.188  Millions
Omeros Corporation  0.93 $ 53.980  Millions$ 57.936  Millions
Protagenic Therapeutics Inc new  0.91 $ 0.754  Millions$ 0.824  Millions
Emergent Biosolutions Inc   0.88 $ 181.500  Millions$ 207.100  Millions
Inhibitor Therapeutics Inc   0.88 $ 0.303  Millions$ 0.346  Millions
Assertio Holdings inc   0.87 $ 105.973  Millions$ 122.293  Millions
Organogenesis Holdings Inc   0.86 $ 46.898  Millions$ 54.825  Millions
Aridis Pharmaceuticals Inc   0.84 $ 16.324  Millions$ 19.443  Millions
Amphastar Pharmaceuticals Inc   0.83 $ 69.338  Millions$ 83.371  Millions
Zomedica Corp   0.83 $ 1.497  Millions$ 1.802  Millions
Johnson and Johnson  0.82 $ 18,024.000  Millions$ 22,081.000  Millions
Avid Bioservices Inc   0.82 $ 36.262  Millions$ 44.480  Millions
Aslan Pharmaceuticals Limited  0.79 $ 14.324  Millions$ 18.084  Millions
Sanofi  0.77 $ 16,973.600  Millions$ 22,114.400  Millions
Ainos Inc   0.72 $ 0.290  Millions$ 0.400  Millions
Evofem Biosciences Inc   0.71 $ 10.271  Millions$ 14.461  Millions
Vbi Vaccines Inc  0.68 $ 35.803  Millions$ 52.851  Millions
Procyon Corporation  0.67 $ 0.277  Millions$ 0.411  Millions
Catalent Inc   0.66 $ 608.400  Millions$ 917.100  Millions
Amag Pharmaceuticals inc   0.66 $ 124.743  Millions$ 188.246  Millions
Mallinckrodt Plc  0.63 $ 808.000  Millions$ 1,284.100  Millions
Neos Therapeutics Inc   0.61 $ 31.850  Millions$ 52.158  Millions
Teligent Inc   0.61 $ 11.028  Millions$ 18.119  Millions
Cv Sciences Inc   0.61 $ 7.097  Millions$ 11.694  Millions
Prestige Consumer Healthcare Inc   0.59 $ 94.760  Millions$ 160.250  Millions
Ampio Pharmaceuticals inc   0.57 $ 2.415  Millions$ 4.214  Millions
Mannkind Corporation  0.57 $ 38.868  Millions$ 68.248  Millions
Intelgenx Technologies Corp   0.56 $ 4.367  Millions$ 7.856  Millions
Histogen Inc   0.55 $ 0.507  Millions$ 0.916  Millions
Reliv International Inc  0.55 $ 2.829  Millions$ 5.124  Millions

Date modified: 2026-09-08T15:09:55+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.